ÌÇÐÄvlog¹ÙÍø

Authors:

  • Christopher Sudfeld
Background: Kidney disease is a growing non-AIDS-related comorbidity among people living with HIV (PLWH). Tenofovir disoproxil fumarate (TDF) can result in proximal tubulopathy and acute tubular injury, whereas atazanavir/ritonavir (ATV/r) can cause interstitial nephritis and renal stones, both of which can lead to chronic kidney disease. Objectives: To examine the relationship between second-line combination antiretroviral therapy (ART) and the risk of kidney disease and morphological changes among PLWH in Dar es Salaam, Tanzania. Method: A cross-sectional study of adult PLWH receiving TDF-based second-line ART. Socio-demographic and clinical data were gathered, and laboratory tests were conducted to determine the estimated glomerular filtration rate (eGFR). Ultrasonography was performed to visualise the kidneys.

Citations

Mugusi SF, Shayo GA, Sasi PG, Fundikira LS, Aris EA, Sudfeld CR, and Mugusi FM. 2025. Kidney disease among adults on tenofovir-based second-line antiretroviral therapy in Dar es Salaam, Tanzania. Southern African Journal of HIV Medicine 26, no. 1: 1640.